Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.64 USD | -1.27% | +3.36% | +71.03% |
20/05 | Enliven Therapeutics Insider Sold Shares Worth $22,877,262, According to a Recent SEC Filing | MT |
14/05 | Enliven Therapeutics Q1 Loss Narrows | MT |
- Stock Market
- Equities
- ELVN Stock
- News Enliven Therapeutics, Inc.
- Other languages